Drugs / Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R
Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01147627 Comparator | Aug 2010 → Aug 2012 | type 2 diabetes mellitus | Sun Yat-sen University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01147627 ↗ |
| Modality | Protein / enzyme biologic | “premixed insulin analog” NCT01147627 ↗ |